Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Sigma Healthcare Ltd ( (AU:SIG) ).
Sigma Healthcare Ltd has announced a significant change in the shareholding interests of its director, Danielle Di Pilla. Over the course of four days in May 2025, Di Pilla disposed of a substantial number of shares, reducing her direct holdings from 61,243,218 to 31,401,068 ordinary shares. This change, executed through on-market trades, reflects a strategic decision that may impact the company’s stock market presence and influence shareholder perceptions.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, focusing on the distribution of pharmaceutical products and services. The company is a key player in the Australian market, providing a range of healthcare solutions to pharmacies and hospitals.
Average Trading Volume: 35,129,171
Technical Sentiment Signal: Buy
Current Market Cap: A$36.4B
For a thorough assessment of SIG stock, go to TipRanks’ Stock Analysis page.